Jonathan A. Bernstein, MD

Quick facts

Marketed products

• Dupilumab Prefilled Syringe · Immunology; Allergy/Atopy
  Dupilumab is a monoclonal antibody that blocks the IL-4 receptor alpha subunit, inhibiting signaling of IL-4 and IL-13 cytokines involved in type 2 inflammation.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Jonathan A. Bernstein, MD portfolio CI brief
• Jonathan A. Bernstein, MD pipeline updates RSS